… and subcutaneous tissue of obese patients undergoing bariatric surgery, compared with a
… were distinctly lower in the obese group than in the non-obese group, but decreased more …

… The optimal IV dose for skin and soft tissue infections in patients with normal renal …
cefazolin concentrations, but significantly lower unbound cefazolin ISF in obese versus non-obese …

… /tazobactam, fosfomcyine, cefazolin, metronidazole and as … /m 2 for obese or between 18.5
and 30 kg/m 2 for non-obese … cut-off 20,000 Da, CMA, Kista, Sweden) were placed into the …

… of surgical patients were only marginally different between obese and non-obese patients,
the drug exposure in subcutaneous tissue was significantly lower in the obese patients. …

… the recommended dose or weight or BMI cut-off values [6, 7]. … of cefazolin may be inadequate
in morbidly obese patients … SSI prevalence between obese and non-obese patients, or …

… , we accrued obese and non-obese patients undergoing … free linezolid concentrations in
soft tissue by microdialysis. … at a subcutaneous target site, in morbidly obese patients and …

… We used a reduction of AIC for statistical … of cefazolin after 2 hours may be required to be
certain of achieving target concentrations of >2 mg·L −1 in the ISF of subcutaneous tissue in …

… of SSIs in obese and non-obese patients (BMI ≥ 30kg/m2 and < … the standard 2g dose of
cefazolin preoperatively. A 5-year … of skeletal and subcutaneous tissues in obese compared to …

… reduce the efficacy of a standard dose for non-obese … in the cohort with obesity compared to
the non-obese cohort, … g doses in plasma and subcutaneous tissue concentrations and used …

… lipophilicity of cefuroxime is lower than cefazolin (Log p … cefazolin in non–pregnant, non–obese
subjects as well as in … simulated cefazolin total adipose concentrations in morbidly obese …